As expected, our data demonstrated that Au-si-CYP2S1 selectively inhibited BRAFV600E-mutated thyroid cancer cells, while almost did not affect the growth of BRAFV600E wild-type ones. Here, CYP2S1 is linked to thyroid gland carcinoma.